NRXP COVID-19 Vaccine Effectiveness Against Delta Variant

NRx Pharmaceuticals announced that its BriLife COVID-19 Vaccine is Effectiveness Against Delta Variant.
Information was released by Israel Institute for Biological Research.

Since the pandemic isn`t over, there is a place in the market for new developers that have effective vaccines.

I consider this a premium call, the upside i see here is 400%, or the 24usd resistance.

NRXP 52 Week Range 4.07 - 76.99usd. Now the price is 6.75usd.

Is this a buy or not?

Market Cap of only 396.97Mil